Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Laura Hughes to Male

This is a "connection" page, showing publications Laura Hughes has written about Male.

 
Connection Strength
  
 
 
0.256
  
  1. Hughes LE, Adams NE, Rouse MA, Naessens M, Shaw A, Murley AG, Cope TE, Holland N, Nesbitt D, Street D, Whiteside DJ, Rowe JB. GABAergic modulation of beta power enhances motor adaptation in frontotemporal lobar degeneration. Alzheimers Dement. 2025 05; 21(5):e14531.
    View in: PubMed
    Score: 0.032
  2. Hughes LE, Rittman T, Robbins TW, Rowe JB. Reorganization of cortical oscillatory dynamics underlying disinhibition in frontotemporal dementia. Brain. 2018 08 01; 141(8):2486-2499.
    View in: PubMed
    Score: 0.021
  3. Hughes LE, Rittman T, Regenthal R, Robbins TW, Rowe JB. Improving response inhibition systems in frontotemporal dementia with citalopram. Brain. 2015 Jul; 138(Pt 7):1961-75.
    View in: PubMed
    Score: 0.016
  4. Hughes LE, Rowe JB, Ghosh BC, Carlyon RP, Plack CJ, Gockel HE. The binaural masking level difference: cortical correlates persist despite severe brain stem atrophy in progressive supranuclear palsy. J Neurophysiol. 2014 Dec 15; 112(12):3086-94.
    View in: PubMed
    Score: 0.016
  5. Hughes LE, Rowe JB. The impact of neurodegeneration on network connectivity: a study of change detection in frontotemporal dementia. J Cogn Neurosci. 2013 May; 25(5):802-13.
    View in: PubMed
    Score: 0.014
  6. Hughes LE, Altena E, Barker RA, Rowe JB. Perseveration and choice in Parkinson's disease: the impact of progressive frontostriatal dysfunction on action decisions. Cereb Cortex. 2013 Jul; 23(7):1572-81.
    View in: PubMed
    Score: 0.013
  7. Hughes LE, Nestor PJ, Hodges JR, Rowe JB. Magnetoencephalography of frontotemporal dementia: spatiotemporally localized changes during semantic decisions. Brain. 2011 Sep; 134(Pt 9):2513-22.
    View in: PubMed
    Score: 0.013
  8. Hughes LE, Barker RA, Owen AM, Rowe JB. Parkinson's disease and healthy aging: independent and interacting effects on action selection. Hum Brain Mapp. 2010 Dec; 31(12):1886-99.
    View in: PubMed
    Score: 0.011
  9. Hughes LE, Bates TC, Aimola Davies AM. Dissociations in rod bisection: the effect of viewing conditions on perception and action. Cortex. 2008 Oct; 44(9):1279-87.
    View in: PubMed
    Score: 0.010
  10. Whiteside DJ, Rouse MA, Jones PS, Coyle-Gilchrist I, Murley AG, Stockton K, Hughes LE, Bethlehem RAI, Warrier V, Lambon Ralph MA, Rittman T, Rowe JB. The presymptomatic and early manifestations of semantic dementia. Brain. 2026 May 05; 149(5):1663-1678.
    View in: PubMed
    Score: 0.009
  11. Lanskey JH, Jafarian A, Hughes LE, Karadag M, Kocagoncu E, Rouse MA, Adams NE, Naessens M, Raymont V, Woolrich M, Singh KD, Henson RN, Rowe JB. Alzheimer's disease and memantine effects on NMDA-receptor blockade: non-invasive in vivo insights from magnetoencephalography. Mol Psychiatry. 2026 Mar; 31(3):1587-1596.
    View in: PubMed
    Score: 0.008
  12. Hughes LE, Bates TC, Aimola Davies AM. The effects of local and global processing demands on perception and action. Brain Cogn. 2005 Oct; 59(1):71-81.
    View in: PubMed
    Score: 0.008
  13. Perry A, Hughes LE, Adams NE, Naessens M, Kloosterman NA, Rouse MA, Murley AG, Street D, Jones PS, Rowe JB. Frontotemporal lobar degeneration changes neuronal beta-frequency dynamics during the mismatch negativity response. Neuroimage Clin. 2024; 44:103671.
    View in: PubMed
    Score: 0.008
  14. Hughes LE, Bates TC, Aimola Davies A. Grasping at sticks: pseudoneglect for perception but not action. Exp Brain Res. 2004 Aug; 157(3):397-402.
    View in: PubMed
    Score: 0.008
  15. Hughes LE, Wilkins AJ. Reading at a distance: implications for the design of text in children's big books. Br J Educ Psychol. 2002 Jun; 72(Pt 2):213-26.
    View in: PubMed
    Score: 0.007
  16. Kocagoncu E, Nesbitt D, Emery T, Hughes LE, Henson RN, Rowe JB. Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease. J Neurosci. 2022 02 16; 42(7):1362-1373.
    View in: PubMed
    Score: 0.007
  17. Adams NE, Hughes LE, Rouse MA, Phillips HN, Shaw AD, Murley AG, Cope TE, Bevan-Jones WR, Passamonti L, Street D, Holland N, Nesbitt D, Friston K, Rowe JB. GABAergic cortical network physiology in frontotemporal lobar degeneration. Brain. 2021 08 17; 144(7):2135-2145.
    View in: PubMed
    Score: 0.006
  18. Shaw AD, Hughes LE, Moran R, Coyle-Gilchrist I, Rittman T, Rowe JB. In Vivo Assay of Cortical Microcircuitry in Frontotemporal Dementia: A Platform for Experimental Medicine Studies. Cereb Cortex. 2021 02 05; 31(3):1837-1847.
    View in: PubMed
    Score: 0.006
  19. Adams NE, Hughes LE, Phillips HN, Shaw AD, Murley AG, Nesbitt D, Cope TE, Bevan-Jones WR, Passamonti L, Rowe JB. GABA-ergic Dynamics in Human Frontotemporal Networks Confirmed by Pharmaco-Magnetoencephalography. J Neurosci. 2020 02 19; 40(8):1640-1649.
    View in: PubMed
    Score: 0.006
  20. Sami S, Williams N, Hughes LE, Cope TE, Rittman T, Coyle-Gilchrist ITS, Henson RN, Rowe JB. Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype. Brain. 2018 08 01; 141(8):2500-2510.
    View in: PubMed
    Score: 0.005
  21. Rae CL, Nombela C, Rodríguez PV, Ye Z, Hughes LE, Jones PS, Ham T, Rittman T, Coyle-Gilchrist I, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB. Atomoxetine restores the response inhibition network in Parkinson's disease. Brain. 2016 08; 139(Pt 8):2235-48.
    View in: PubMed
    Score: 0.004
  22. Phillips HN, Blenkmann A, Hughes LE, Kochen S, Bekinschtein TA, Rowe JB. Convergent evidence for hierarchical prediction networks from human electrocorticography and magnetoencephalography. Cortex. 2016 09; 82:192-205.
    View in: PubMed
    Score: 0.004
  23. Borchert RJ, Rittman T, Passamonti L, Ye Z, Sami S, Jones SP, Nombela C, Vázquez Rodríguez P, Vatansever D, Rae CL, Hughes LE, Robbins TW, Rowe JB. Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease. Neuropsychopharmacology. 2016 07; 41(8):2171-7.
    View in: PubMed
    Score: 0.004
  24. Zhang J, Rittman T, Nombela C, Fois A, Coyle-Gilchrist I, Barker RA, Hughes LE, Rowe JB. Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease. Brain. 2016 Jan; 139(Pt 1):161-73.
    View in: PubMed
    Score: 0.004
  25. Phillips HN, Blenkmann A, Hughes LE, Bekinschtein TA, Rowe JB. Hierarchical Organization of Frontotemporal Networks for the Prediction of Stimuli across Multiple Dimensions. J Neurosci. 2015 Jun 24; 35(25):9255-64.
    View in: PubMed
    Score: 0.004
  26. Rae CL, Hughes LE, Anderson MC, Rowe JB. The prefrontal cortex achieves inhibitory control by facilitating subcortical motor pathway connectivity. J Neurosci. 2015 Jan 14; 35(2):786-94.
    View in: PubMed
    Score: 0.004
  27. Zhang J, Hughes LE, Rowe JB. Selection and inhibition mechanisms for human voluntary action decisions. Neuroimage. 2012 Oct 15; 63(1):392-402.
    View in: PubMed
    Score: 0.003
  28. Rae CL, Correia MM, Altena E, Hughes LE, Barker RA, Rowe JB. White matter pathology in Parkinson's disease: the effect of imaging protocol differences and relevance to executive function. Neuroimage. 2012 Sep; 62(3):1675-84.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)